EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Functional characterisation of obesity-associated MRAP2 variants on MC4R and GHSR signalling

Alejandra V Rodríguez Rondón, Karina Prins, Femke Volker, Eline E P L van der Walle, Cornelis J de Groot, Erica L T van der Akker, Elisabeth F C van Rossum, Mieke M van Haelst, Patric J D Delhanty, Jenny A Visser iD

Human Molecular Genetics · 2026

DOI: 10.1093/hmg/ddag010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Molecular Genetics, 2026. Verfasst von Alejandra V Rodríguez Rondón und 9 weiteren Autor:innen. Beteiligte Einrichtung: Obesity Centre CGG, Erasmus MC, University Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands. Hauptthemen laut MEDLINE: Receptor, Melanocortin, Type 4, Obesity, Receptors, Ghrelin, Receptor Activity-Modifying Proteins. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanocortin-2 receptor accessory protein-2 (MRAP2) modulates the activity of hypothalamic melanocortin-4 (MC4R) and growth hormone-secretagogue (GHSR) receptors, which suppress and promote appetite, respectively. We investigate whether obesity-associated variants of MRAP2 alter their ability to modulate MC4R and GHSR signalling as a possible mechanistic link to the development of obesity. Functional effects of five obesity-associated MRAP2 variants were analysed in HEK293 cells by co-expressing wild-type or variant MRAP2 with MC4R or GHSR. Endpoints included cell-surface and total expression, and ligand-induced second-messenger responses, β-arrestin-2 recruitment, and alternative G-protein activation. MRAP2 decreased basal MC4R cell-surface expression while GHSR cell-surface expression was not affected. In MC4R/MRAP2 expressing cells, maximal α-MSH-induced cAMP and β-arrestin-2 recruitment responses were increased. Similarly, ghrelin-induced Ca2+-mobilization in GHSR/MRAP2 expressing cells was increased, but β-arrestin-2 recruitment was suppressed. MRAP2 did not bias G-protein activation by either receptor, although previous reports show MRAP2 biases MC4R signalling towards Gαq/11. The variants did not significantly affect the ability of MRAP2 to modulate MC4R and GHSR signalling. Our results indicate that MRAP2 potentiates the ligand responsiveness of MC4R and GHSR, but has differential effects on β-arrestin-2 recruitment. The MRAP2 variants had no significant effects on the signalling endpoints tested. This suggests that, despite their association with obesity, the variants may be functionally benign, or that the absence of effects reflects limitations inherent to our cellular model. In addition, since MRAP2 can modulate multiple receptors and differentially modulate their signalling, we cannot rule out their influence on body weight regulation via other mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Melanocortin, Type 4ObesityReceptors, GhrelinReceptor Activity-Modifying ProteinsHumansHEK293 CellsSignal Transductionbeta-Arrestin 2Cyclic AMPalpha-MSHAdaptor Proteins, Signal Transducing

Stichwörter der Autor:innen

GPCR accessory proteinGPCR signallingMRAP2 variantsObesity

Substanzen

MRAP2 protein, humanReceptor, Melanocortin, Type 4MC4R protein, humanReceptors, GhrelinReceptor Activity-Modifying Proteinsbeta-Arrestin 2Cyclic AMPalpha-MSHAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Obesity Centre CGG, Erasmus MC, University Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands.
  • Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands.
  • Department of Paediatrics, Division of Endocrinology, Erasmus MC-Sophia Children's Hospital, University Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands.
  • Section Clinical Genetics, Department of Human Genetics, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

ORCID-Profile: Jenny A Visser

Zitieren

APA

Rodríguez Rondón, A. V., Prins, K., Volker, F., van der Walle, E. E. P. L., de Groot, C. J., van der Akker, E. L. T., van Rossum, E. F. C., van Haelst, M. M., Delhanty, P. J. D., & Visser, J. A. (2026). Functional characterisation of obesity-associated MRAP2 variants on MC4R and GHSR signalling. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddag010

Vancouver

Rodríguez Rondón AV, Prins K, Volker F, van der Walle EEPL, de Groot CJ, van der Akker ELT, et al. Functional characterisation of obesity-associated MRAP2 variants on MC4R and GHSR signalling. Human Molecular Genetics. 2026. doi:10.1093/hmg/ddag010

BibTeX
@article{RodrguezRondn2026,
  author = {Rodríguez Rondón, Alejandra V and Prins, Karina and Volker, Femke and van der Walle, Eline E P L and de Groot, Cornelis J and van der Akker, Erica L T and van Rossum, Elisabeth F C and van Haelst, Mieke M and Delhanty, Patric J D and Visser, Jenny A},
  title = {Functional characterisation of obesity-associated MRAP2 variants on MC4R and GHSR signalling},
  journal = {Human Molecular Genetics},
  year = {2026},
  doi = {10.1093/hmg/ddag010}
}
Kostenlos starten →